comparemela.com

Latest Breaking News On - Patricia steinert - Page 1 : comparemela.com

Children Treated With Remestemcel-L Show Long-Term Survival

Key Points: Long-term survival evident through 4 years in children treated with remestemcel-L in Phase 3 trial MSB-GVHD001Overall survival at 2 years.

United statesJoanne kurtzbergSilviu itescuSteve dabkowskiPatricia steinertPaul hughesMarrow transplant researchInternational bloodAustralian securities exchangeMarrow transplantation groupDuke university medical centerMesoblast limited nasdaqCorporate communications investorsDrug administrationNational marrow donor programInternational blood marrow

Children Treated With Remestemcel-L Show Long-Term Survival Through Four Years in Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)

23.11.2022 - Key Points: Long-term survival evident through 4 years in children treated with remestemcel-L in Phase 3 trial MSB-GVHD001Overall survival at 2 years was 51% in remestemcel-L treated children and 25-38% in recently published studies of children . Seite 1

United statesJoanne kurtzbergPatricia steinertDuke university medical centerMesoblast limited nasdaqMarrow transplant researchDrug administrationInternational bloodInternational blood marrowDepartment of medicine centerKey pointsBiologics license applicationUnited states foodJerome harrisDistinguished professorExecutive scientific director

vimarsana © 2020. All Rights Reserved.